Skip to main content

BIIB Competitors

profileAnalyst coverage5 yr. financialspremium researchdividendsadv. chartsearningsoptionsprice historyeventsinsiders

Biogen Inc. News

Stock Market Today - 5/3: Stocks End Higher Amid Fed Rate Hike Bets; Treasury Yields Ease

Stocks finish higher Tuesday as the Federal Reserve begins its two-day policy meeting amid bets on faster and deeper near-term rate hikes.

Biogen Stock Gains After Q1 Earnings Miss; CEO Michel Vounatsos Exits

"I will be leaving at a time of promise for Biogen, with noteworthy potential for value creation," said departing CEO Michel Vounatsos.

Should Biogen Investors Be Worried About Its Alzheimer's Drug?

A Medicare policy decision might hurt sales of this biotech giant's Alzheimer's drug.

Biogen's ALS Drug Won't Move Forward After Trial Failures

Biogen will stop developing a drug to treat a severe neurodegenerative disease, as it did not show sufficient benefit when tested in trials.

Novartis and Roche Have Expensive Drugs That Scare Away Competitors

A brief snapshot of some medical breakthroughs that are among the costliest in the world.

Breaking News

Donald Trump Media SPAC Digital World Acquisition Gets Subpoenas Linked To Grand Jury Probe

"These subpoenas ... could materially delay, materially impede, or prevent" DWAC's planned merger with Trump Media & Technology Group.

General Electric Stock Gains As CEO Larry Culp Takes Over Aviation Division

"There is tremendous opportunity in aviation over the coming years, and the Board and I decided it is the right time for me to take on this expanded role," said GE CEO Larry Culp.

Barstool's Portnoy Takes a Surprising Stand on a Key Political Issue

The outspoken Republican with a platform voices his opinion on the state of democracy moving to the right.

McDonald's Brings Back a Classic Menu Item (with a Catch)

You never know what the fast-food chain might bring back or create a new version of.